Skin Disorder Research

Mercy Research studies examine the diagnosis, treatment, prognosis and prevention of diseases and conditions related to Skin Disorders (Dermatology).

Studies include disorders associated with the skin, scalp, hair and nails: acne, dermatitis, eczema, psoriasis, skin wounds, rashes, skin cancers and other skin disorders.

Community Project Title Study Details Sponsor Contact Study Site

Acne Vulgaris

Washington A Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris
 
Learn more Allergan Mercy Health Research Washington

Cellulite

Washington A Phase 2, Randomized, Double-blind, Placebo Controlled Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy Learn more Auxilium Pharmaceuticals Mercy Health Research Washington

Hypertrophic Scar

St. Louis A Study to Evaluate the Effectiveness and Safety of RXI 109 on the Outcome of Scar Revision Surgery in Healthy Adults Learn more RXi Pharmaceuticals, Corp Mercy Health Research

Keloids

St. Louis A Multi-Center, Prospective, Randomized, Single-Blind, Within-Subject Controlled Phase 2a Study to Evaluate the Effectiveness and Safety of RXI-109 on the Outcome of Keloid Excision Surgery in Healthy Adults Learn more RXi Pharmaceuticals Mercy Health Research

Malignant Skin Melonoma

Oklahoma City Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma Learn more Notrh Central Cancer Treatment Group Mercy Clinic Oncology and Hematolgy McAuley

Melanoma

St. Louis Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery Learn more Eastern Cooperative Oncology Group Mercy Oncology Research-David C Pratt Cancer Center
Fort Smith Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery Learn more Eastern Cooperative Oncology Group Mercy Medical Research - Fort Smith

Skin Melanoma

Oklahoma City Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma Learn more North Central Cancer Treatment Group Mercy Clinic Oncology and Hematolgy McAuley
Oklahoma City Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery Learn more National Cancer Institute  Mercy Clinic Oncology and Hematolgy McAuley

 

About this Service

Top News

Sustainability initiatives save money and the planet.
Mercy's Dr. Joseph Drozda is in the spotlight once again.
Subscribe to Mercy News Coverage

Career Center see all